The Enkephalinergic Osteoblast
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BONES DEPEND ON CONTINUOUS cellular regulatory processes throughout all phases of their life. It starts in histogenesis when bones are formed by transformation of pre-existing connective tissue into bone tissue. Flat bones of the skull are formed by intramembranous ossification, the transformation of primitive connective tissue into bone. Long bones are formed by endochondral ossification, the replacement of cartilage by bone. Next, bones undergo growth and modeling, and finally they are continuously remodeled throughout life. Repair of bone injury includes events resembling the processes that occur in endochondral ossification during bone development. Cells of the osteoclastic and osteoblastic lineages are key players in performing these complex processes. These cells are mainly regulated on three levels: replication of undifferentiated cells; differentiation and recruitment of cells, and differentiated function of cells. Extensive studies revealed that the regulation of metabolic functions of bone cells is executed by hormones, carried in the blood to their target organ, the bone, as well as by local factors that are synthesized in the bone and act in a paracrine/autocrine manner. The best known such systemic hormones include parathyroid hormone (PTH), sex steroids, glucocorticoids, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), and calcitonin, while the local factors include mediators such as cytokines, platelet-derived growth factor, basic fibroblast growth factor and transforming growth factor-β (TGF-β) (see reviews in Refs. 1 and 2). The innervation of bones, especially with peptidergic nerves, together with functional studies suggest that neuropeptides may also play a role in bone metabolism. These functional studies support the notion that the nervous system is involved in embryonal development, fracture healing, bone remodeling, and bone formation (reviewed in Ref. 3). Neuropeptides released from the sensory nerve fibers and from postganglionic, autonomic nerve fibers probably mediate at least some of these effects. These neuropeptides may affect bone metabolism via interaction with and modulation of bone cells, as well as modulation of mast cells, monocytes/macrophages, and endothelial cells. Thus, regulatory peptides, known for their actions in the nervous and the neuroendocrine systems, are also capable of modulating functions of bone cells, and therefore serve as modulators of bone development, growth, modeling, and remodeling. Immunohistochemical studies revealed the occurrence of vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide, substance P, neuropeptide Y, and norepinephrine (NE) in osseal nerve fibers.4,5 The abundance of these nerves in regions of high osteogenic activity (i.e., growth plate) is consistent with the hypothesis of neurogenic influence on local bone metabolic processes. Furthermore, VIP, calcitonin gene-related peptide, NE, and neuropeptide Y had stimulatory effects on osteoblastic cAMP levels, suggesting that these neuropeptides may act as modulators of bone cell activity. Neurotransmitters are also capable of modulating cytosolic calcium in osteoblastic cells: NE and VIP transiently increased cytosolic Ca2+ concentrations.6 Another line of evidence is studies on the presence of various neuropeptide/neurotransmitter receptors in bones and bone cells. For example, analyses during endochondral ossification in long bones of neonatal rats showed a specific pattern of somatostatin receptor expression. The expressing cells were probably osteoblast precursors, while no binding of somatostatin could be demonstrated in chondrocytes, osteoclasts, and mature osteoblasts. It was suggested, therefore, that somatostatin, in addition to its known functions as a modulator of neural activity and of endocrine and exocrine secretion, is also involved in the regulation of osteoblast differentiation during endochondral bone formation.7 It is worth mentioning, that in addition to the direct effects of nervous system-derived peptides on bone cells, the neuropeptides' effects on bone metabolism also may be obtained indirectly. This can be shown by modulation of other cell types, such as mast cells, monocytes/macrophages, and endothelial cells.8 On the one hand, these cells express functional neuropeptide receptors modulating their functions, and on the other hand, they (or their products) affect bone cell functions. We can also learn about the importance of neuropeptides in regulating bone metabolism from changes in neuropeptides containing nerves in various pathological conditions, such as arthritis, fracture healing, and heterotopic bone formation in demineralized allogeneic bone matrix (reviewed in Ref. 3). The source of all these bone-cell modulating peptides is the nervous system elements innervating the bones. Several years ago, while studying the involvement of neuropeptides in developmental processes, we made the surprising observation that bone cells express a group of neu
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · cited 1×
“These animals show a complete loss of analgesic responses to morphine as well as loss of place-preference activity and physical dependence on this opioid.((23)) Interestingly, lack of a functional receptor resulted in changes in both the host defense system and the reproductive system.”
BackgroundBjurholm, A., Kreicbergs, A., Schultzberg, M., & Dr. Lerner, U. H. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070903 · Cited by 145 · cited 1×
“related peptide, substance P, neuropeptide Y, and norepinephrine (NE) in osseal nerve fibers.((4,5)) The abundance of”
Background
Cited by
Low bone density in patients receiving methadone maintenance treatment
Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.027 · Cited by 131
Pérez-Castrillón, J. L., Olmos, J. M., Gómez, J. J., Barrallo, A., Riancho, J. A., Perera, L., Valero, C., Amado, J. A., & González-Macías, J. (2000) · Neuroendocrinology · doi:10.1159/000054586 · Cited by 99
Tanaka, K., Kondo, H., Hamamura, K., & Togari, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.069 · Cited by 21
Effects of remifentanil preconditioning on osteoblasts under hypoxia-reoxygenation condition
Baik, S.-W., Park, B.-S., Kim, Y.-H., Kim, Y.-D., Kim, C.-H., Yoon, J.-Y., & Yoon, J.-U. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11839 · Cited by 14
Metadata
- Authors
- Rosen, H., Krichevsky, A., & Bar-Shavit, Z.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-10-01
- Volume
- 13
- Issue
- 10
- Pages
- 1515-1520
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2059845455
- Cited by
- 28
- References
- 2
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Enkephalinergic Osteoblast. https://app.cochat.ai/papers/10.1359/jbmr.1998.13.10.1515
- The paper
- Rosen, H., Krichevsky, A., & Bar-Shavit, Z. (1998). The Enkephalinergic Osteoblast. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.1998.13.10.1515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.